549 related articles for article (PubMed ID: 12692517)
1. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
3. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
Sorensen PH; Chen CS; Smith FO; Arthur DC; Domer PH; Bernstein ID; Korsmeyer SJ; Hammond GD; Kersey JH
J Clin Invest; 1994 Jan; 93(1):429-37. PubMed ID: 8282816
[TBL] [Abstract][Full Text] [Related]
4. Acute monocytic leukemia with chloroacetate esterase positivity. FAB M4 or M5?
Rosenthal NS; Farhi DC
Am J Clin Pathol; 1992 Jul; 98(1):41-5. PubMed ID: 1615924
[TBL] [Abstract][Full Text] [Related]
5. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies differentiating between monocytic and nonmonocytic variants of AML.
Linch DC; Allen C; Beverley PC; Bynoe AG; Scott CS; Hogg N
Blood; 1984 Mar; 63(3):566-73. PubMed ID: 6365201
[TBL] [Abstract][Full Text] [Related]
7. Expression of a monocyte-specific esterase isoenzyme in cases of acute myeloid leukemias.
Drexler HG; Klein M; Bhoopalam N; Menon M; Messmore HL; Gaedicke G; Minowada J
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1485-91. PubMed ID: 3868620
[TBL] [Abstract][Full Text] [Related]
8. The use of monoclonal antibody Y1/82A in the identification of acute myeloblastic and monocytic leukemias.
Davey FR; Erber WN; Gatter KC; Mason DY
Am J Clin Pathol; 1988 Jan; 89(1):76-80. PubMed ID: 3422117
[TBL] [Abstract][Full Text] [Related]
9. [Esterases in the diagnosis of monocytic and myelomonocytic leukemias and the so-called atypical monocytes in myelodysplastic syndromes].
Malasková V; Koubek K; Dorazilová V; Horský J
Sb Lek; 1988 Sep; 90(8-9):260-7. PubMed ID: 3201089
[No Abstract] [Full Text] [Related]
10. Distinct lysozyme content in different subtypes of acute myeloid leukaemic cells: an ultrastructural immunogold study.
Resnitzky P; Shaft D
Br J Haematol; 1994 Oct; 88(2):357-63. PubMed ID: 7803282
[TBL] [Abstract][Full Text] [Related]
11. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
12. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis.
Drexler HG; Menon M; Gaedicke G; Minowada J
Cancer Immunol Immunother; 1986; 21(3):188-92. PubMed ID: 3457629
[TBL] [Abstract][Full Text] [Related]
13. Acute monocytic leukemia with chloroacetate esterase positivity: FAB M4 or M5?
Miller-Canfield P; Dubell J; Schumacher HR
Am J Clin Pathol; 1993 Jul; 100(1):84. PubMed ID: 8240517
[No Abstract] [Full Text] [Related]
14. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
15. Epithelial membrane antigen (EMA) or MUC1 expression in monocytes and monoblasts.
Leong CF; Raudhawati O; Cheong SK; Sivagengei K; Noor Hamidah H
Pathology; 2003 Oct; 35(5):422-7. PubMed ID: 14555387
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
Legrand O; Zompi S; Perrot JY; Faussat AM; Benderra Z; Chaoui D; Marie JP
Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic application of monoclonal antibody KB90 (CD11c) in acute myeloid leukaemia.
Master PS; Richards SJ; Kendall J; Roberts BE; Scott CS
Blut; 1989 Sep; 59(3):221-5. PubMed ID: 2477088
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia-FAB classification and its correlation with clinico-haematological features.
Hassan K; Qureshi M; Shafi S; Ikram N; Akhtar MJ
J Pak Med Assoc; 1993 Oct; 43(10):200-3. PubMed ID: 8114248
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry immunophenotypic characteristics of monocytic population in acute monocytic leukemia (AML-M5), acute myelomonocytic leukemia (AML-M4), and chronic myelomonocytic leukemia (CMML).
Gorczyca W
Methods Cell Biol; 2004; 75():665-77. PubMed ID: 15603447
[No Abstract] [Full Text] [Related]
20. Nonspecific esterase staining patterns in acute monocytic leukemia.
Wrotnowski U; Innes DJ; Hobson AS
Am J Clin Pathol; 1987 Apr; 87(4):515-8. PubMed ID: 2435147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
